NAMS vs UAA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NAMS · NewAmsterdam Pharma$18.90 ▲ 0.05%
UAA · Under Armour-A$5.28 ▼ 5.21%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NAMS -51.5%
- UAA +17.9%
Head to head
| Metric | NAMS | UAA |
|---|---|---|
| Price | $18.90 | $5.28 |
| Change today | ▲ 0.05% | ▼ 5.21% |
| Market cap | $2.27B | $2.27B |
| Return, 3 months | -32.5% | -10.1% |
| Return, year to date | -46.1% | +6.2% |
| Return, 1 year | -48.6% | +13.3% |
| P/E (TTM) | – | – |
| P/B | 3.6 | 1.6 |
| P/E percentile vs own 5y | 56th | 37th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -80.7% | -3.2% |
| Net profit growth (YoY) | -269.4% | +120.9% |
| Gross margin | – | 46.8% |
| Operating margin | -3,432.2% | 0.0% |
| Net margin | -3,644.2% | -10.0% |
| Return on equity | -36.8% | -29.8% |
| Analyst target vs. price | +180.4% | +5.9% |
| Analyst buy share | 100% | 15% |
| RSI (14) | 38 | 56 |
| 30-day volatility | 60.0% | 51.8% |
| Max drawdown, 1 year | -54.4% | -47.5% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UAA is the largest of the group by market value.
- UAA has returned the most over the past year.
- UAA is growing revenue fastest.
- UAA keeps the most profit per dollar of sales.
- UAA has been the calmest stock over the last 30 days.